⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of SCOPE International AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
SCOPE International AG
↗Mannheim, Germany
SCOPE International is an independent, full-service Contract Research Organization (CRO) based in Germany. The company provides a comprehensive range of clinical development and consulting services, including strategic planning, clinical phases I–IV, safety management, data management, and regulatory affairs for the pharmaceutical, biotechnology, and medical device industries.
Founded in 2000, the company operates with a network of offices across Europe and the USA, supported by a global partner network. They focus on delivering tailored clinical research solutions with an emphasis on cost-effectiveness, quality, and adherence to international standards.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:N/A
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Medidata Solutions (Technology partner)
COMPETITION
Position:Niche Player
Competitors:ICON, IQVIA, Parexel, Syneos Health
LEADERSHIP
Key Executives:
Stephane Cousté - Founder & CEO
LINKS
Website:scope-international.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with SCOPE International AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.